# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 54


In regulation 72 (validity of conditional marketing authorisation and variation of a UK marketing authorisation), in the inserted regulation 65C—
(a) in the heading to the regulation, for “UK marketing authorisation” substitute “UKMA(GB)”;
(b) in paragraphs (1) and (3), for “UK marketing authorisation” substitute “UKMA(GB)”;
(c) in paragraph (6), for “exit day” in each place it occurs substitute “IP completion day”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/54 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-54
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.